On 20th May, 2019, BCR (thebcr.com.en) was invited by the University of Sydney, to co-host in the establishment ceremony of the BCR PhD Scholarship held at the University of Sydney Brain and Mind Centre.
Through funding this scholarship, BCR aims to provide a long-term support for the talent introduction program of Brain and Mind Centre. As for USYD, it aims to utilise the BCR PhD Scholarship in order to recruit young talents from prestigious universities globally; to take advantage of artificial intelligence technology in the field of medical imaging jointly to diagnose and to treat brain-related diseases accurately. For examples; Parkinson disease, Alzheimer disease and Multiple Sclerosis.
During this meaningful event, BCR senior executives, world-renowned scientific experts, as well as the world’s top three clinical professors, the COO and CEO of the Brain and Mind Centre were present.
Professor John D Pollard (AO) and Professor Patricia Armati (AM, BSc, MSc, PhD) delivered a speech on the establishment of Nerve Research Foundation.
Professor Pollard is internationally recognized for his reputation in the fields of neuropathy and multiple sclerosis, in 2005, he was awarded an AO for his contributions to neurology and in particular to multiple sclerosis.
Professor Armati is the Founder, Co-Director and Vice President of the Nerve Research Foundation. She is also a member of the Advisory Committee of the Institute of Neuromuscular Research, Westmead Childrens Hospital.
Lastly, Professor Michael Barnett (MBBS, FRACP, PhD) and Dr Tim Wang explained the major research and achievements of the Brain and Mind Centre. Professor Michael Barnett is a consultant neurologist at The Royal Prince Alfred Hospital Sydney, a Director of the MS Society clinic and MS clinical Trials Unit at the Brain and Mind Centre. Dr. Tim Wang is a postdoctoral researcher at the Brain and Mind Centre and the Director of Operations at Sydney Neuroimaging Analysis Centre.
(BCR Allen Chen, Professor Michael Barnett, Professor John D Pollard, Professor Patricia Armati, BCR Director David Calver)
It is universally known that in the medical imaging field, “AI” is still in its’ infancy, but we deem that as technology matures, not only will it enhance our working efficiency, but it aids to improve the accuracy of medical imaging that will contribute to various treatments for patients with brain diseases. We are convinced that AI, the new advanced technology, will be applied in every aspect of the medical field to serve a better society to benefit mankind.
(Professor John D Pollard, BCR Sales Director Anna Zhang)
Undoubtedly, the funding of BCR PhD Scholarship will significantly promote the introduction of medical professional talents. What’ more, coupled with the trend of our times, the excellent match of “Talents + AI” will create profound achievements in clinical medicine and denervation in brain and mind. BCR will be in the integrity of the purpose of “Development medicine and dedication to society” to develop its’ business on the basis of national health to further exploit uncharted territory in medical field. BCR expects that emerged multitude talents with professional knowledge and dedication spirit can become a solid backing for medical development.
Bacera Co Pty Ltd doing business as “BCR” (ACN 130 877 137) is licensed and regulated by the Australian Securities and Investments Commission and holds an Australian Financial Services License #328794.
BCR Co Pty Ltd (BVI Company Number 1975046) is licensed regulated by the BVI Financial Services Commission and holds BVI FSC license #SIBA/ L/19/1122.
Browse thebcr.com for further information on BCR.